TARGETED AND HIGH DENSITY DRUG LOADED POLYMERIC MATERIALS

(19)

(11)

EP 1 768 692 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	17.06.2015 Bulletin 2015/25

(45)	Mention of the grant of the patent:
	25.03.2015 Bulletin 2015/13

(21)	Application number: 05856870.0

(22)	Date of filing: 30.06.2005

(51)

International Patent Classification (IPC):

A61K 9/16^(2006.01)
A61K 47/48^(2006.01)
A61L 24/00^(2006.01)
A61L 31/00^(2006.01)

A61K 9/51^(2006.01)
G01N 33/543^(2006.01)
A61L 27/00^(2006.01)

(86)	International application number:
	PCT/US2005/023444

(87)	International publication number:
	WO 2006/080951 (03.08.2006 Gazette 2006/31)

(54)	TARGETED AND HIGH DENSITY DRUG LOADED POLYMERIC MATERIALS MIT WIRKSTOFF BELADENE POLYMERMATERIALIEN VON HOHER DICHTE UND MIT ZIELAUSRICHTUNG MATERIAUX POLYMÈRES CHARGÉS DE MÉDICAMENTS ET CIBLÉS À HAUTE DENSITÉ

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30)

Priority:

01.07.2004 US 585047 P
07.10.2004 US 616821 P
17.11.2004 US 628778 P
05.05.2005 US 677991 P

(43)	Date of publication of application:
	04.04.2007 Bulletin 2007/14

(73)	Proprietor: Yale University
	New Haven, CT 06510 (US)

(72)	Inventors:
	SALTZMAN, William, Mark New Haven, Connecticut 06515 (US) FAHMY, Tarek New Haven, Connecticut 06515 (US) FONG, Peter New Haven, Connecticut 06511 (US)

(74)	Representative: Hoffmann Eitle
	Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München 81925 München (DE)

(56)

References cited: :

WO-A1-02/076441
WO-A2-2005/021730
US-A1- 2002 044 959
US-B2- 6 793 938

WO-A2-03/087021
US-A- 5 543 158
US-B1- 6 544 543

CANNIZZARO S M ET AL: "A novel biotinylated degradable polymer for cell-interactive applications", BIOTECHNOLOGY AND BIOENGINEERING, WILEY & SONS, HOBOKEN, NJ, US, vol. 58, no. 5, 5 June 1998 (1998-06-05), pages 529-535, XP002976886, ISSN: 0006-3592, DOI: 10.1002/(SICI)1097-0290(19980605)58:5<529: :AID-BIT9>3.0.CO;2-F
HATTORI ET AL.: 'Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer' JOURNAL OF CONTROLLED RELEASE vol. 97, 2004, pages 173 - 183, XP004508985

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).